Navigation Links
Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2008 Financial Results
Date:2/9/2009

Bad debt expense 6,227 6,185 Depreciation and amortization expense 28,909 32,586 Operating income 97,064 99,526 Interest expense, net 3,385 8,535 Income before income taxes 93,679 90,991 Income taxes 35,513 33,403 Net income $58,166 $57,588 Basic earnings per common share $0.79 $0.73 Diluted earnings per common share $0.79 $0.70 Weighted average number of common shares outstanding 73,464,442 78,500,270 Weighted average number of common shares and common share equivalents outstanding 73,533,442 84,293,285 For the twelve months ended December 31, December 31, 2008 2007 Net revenues $1,664,580 $1,595,990 Costs and expenses: Costs of goods and services 400,812 389,884 Operating expenses 395,706 365,016 Selling, general and administrative expenses 326,886 317,722 Bad debt expense 24,969 23,940 Depreciation and amortization expense 117,527 116,280 Operating income 398,680 383,148 Interest expense, net 17,412 22,480 Income before income taxes 381,268 360,66
'/>"/>
SOURCE Lincare Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results
2. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results
5. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
6. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
7. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
8. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
9. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)... , HOUSTON, Nov. 7 ...esented Lisa James, Director of Health at the Fami... Distinguished Service today at its semi-annual po...ed Service is the highest honor the AMA House of D...: http://www.newscom.com/cgi-bin/prnh/20081209/...
(Date:11/7/2009)... , Brown: "Faithful Catholics have a respon...re, not negotiate the status quo." ,, WASHING... Life League president Judie Brown released the fo... Rigali will support Speaker Nancy Pelosi,s Afford...ided an amendment preserving the status quo for ab...
(Date:11/7/2009)...Parents should not assume that all youth will rebe...hDay News) -- Teens are more likely to behave badl...y has found. , "Parents who believe they are simpl...elf-fulfilling prophecy," Christy Buchanan, a psyc...author of the study, said in a university news rel...
(Date:11/7/2009)..., A new foot spray from G...with the power of hot peppers and caffeine. Therma...g natural formula that also contains Black Walnut,... Schenectady, NY (PRWEB) N...ons fights pain and increases circulation with the...
(Date:11/6/2009)..., WHITE PLAINS, N.Y., Nov. 6 The Leukemia &am...ing in Gap Inc.,s Give & Get program, which in...er, garnered more than $1 million to support LLS,s...on and support services. ,, During the campaign, t...ill issue downloadable 30% discount coupons pa...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2
...y the most common neurological disorder and one of...ve million people die of stroke each year and more...the question of the day is about the recovery - wh...n Maryland devised a method which allows doctors t...
...pe I, is due to autoimmune destruction of the panc... this the body no longer produces insulin and and ...duals with this type I Diabetes develop are at a h... Los Angeles did a study involving 57 diabetics ag...
...one of the common neurological problems affecting ...any underlying disease. If you happen to be one of...aine, then there is a reason to celebrate. Yes, th...gress of Neurology told that tizanidine, can cut t...
...umber of advertisements by the drug companies has ... prescription drug ads from television, news paper...w Jersey delegate Dr. Angelo agro said that such a...ded that ads have tuned into a competition "to see...
...n the density of the bone is lost and becomes brit...after they attain their menopause. This happens as...s responsible for maintaining the bone density. ...nt bone loss after menopause as effectively as est...
...is on the rise. But the alarm bells are soaring ag...female smokers with breast cancer face an increase...other organs than do nonsmokers "There is a re...ifornia at Davis. Dr. Murin says the research m...
Other Medicine News:
(Date:11/6/2009)...IEGO, Nov. 6 Ardea Biosc...pany focused on the development of small-molecule ... human immunodeficiency virus (HIV), today reporte... the third quarter and nine months ended September...cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since our...
(Date:11/6/2009)...ON, Nov. 6 Cyberonics, I...any will report financial results for the second q...nding April 30, 2010 on Wednesday, November 18, 20...ference call to discuss those results on Thursday,...Year 2010 Second Quarter Results Conference Call I...
(Date:11/6/2009)...IT, Nov. 6 Caraco Pharma... launched ketorolac tromethamine ophthalmic soluti...od and Drug Administration (FDA) for Sun Pharma,s ...c Acular® opthalmic solution on the first day...orolac is therapeutically equivalent to Acular...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 1New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 3President Selected to Open Sanford Brown Institute Grand Rapids 60350 1President Selected to Open Sanford Brown Institute Grand Rapids 60350 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
.... (NHSi) has won a two-year award of $1.9 million ...of the National Institutes of Health (NIH) to deve...The project aims to develop the Hemanext Anaerobic...lood for transfusion therapy and extends the shelf...onstrated that this new technology can deliver hig...
...ty for Acute Pain Patients , , RARITAN, N.J., May...people who have surgery experience gastrointestina...se of opioid pain medicines during and after surge... side effects. Nausea and vomiting are uncomfortab...ent,s recovery. , , According to a new Phase 3 cl...
Other Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
SureCut M3500 Fuses, Spare
Feather Disposable Blades, Pack of 50
SureCut M3500 Abrasive, Coarse, Knife Sharpening
SureCut M3500 Standard Knife w/ Box, C Profile
Medicine Products: